HIV trials in Zimbabwe
15 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.
- Phase 4Taking peopleA Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments
- Where
- Harare
- Age
- 1 month and over
- People
- 350 worldwide
- Run by
- Gilead Sciences
See details and how to joinNCT06337032 - No phaseTaking peopleFeasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS7 Zimbabwe
- Where
- Harare
- Age
- 25 years to 49 years
- People
- 300
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT07645352 - Phase 1/2Taking peopleA Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV
- Where
- Chitungwiza, Harare, Seke North
- Age
- Up to 13 years
- People
- 144 worldwide
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT07124559 - No phaseTaking peopleImproving Engagement in HIV and Cancer Care in Zimbabwe
- Where
- Harare
- Age
- 18 years and over
- People
- 300
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT06934369 - Phase 1Taking peopleA Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan Antibodies
- Where
- Harare
- Age
- 18 years to 60 years
- People
- 42 worldwide
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT07569029 - No phaseTaking peopleAdaptation of an Intervention Addressing Barriers to PrEP Use Among Pregnant Women in Zimbabwe
- Where
- Harare
- Age
- 15 years to 55 years
- People
- 165
- Run by
- Massachusetts General Hospital
See details and how to joinNCT06226155 - Phase 1/2Taking peopleVery Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
- Where
- Chitungwiza, Harare
- Age
- Up to 48 hours
- People
- 1,120 worldwide
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT02140255 - No phaseNot yet taking people in ZimbabweClinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women Living With HIV
- Where
- Harare
- Age
- 25 years to 49 years
- People
- 17,734
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT07624123 - Phase 1Taking peopleA Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1
- Where
- Harare
- Age
- 18 years to 55 years
- People
- 83 worldwide
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT07390955 - No phaseNot yet taking people in ZimbabweThe 'Comprehensive Adherence Resource and Empowerment Support' (CARES) Study
- Where
- Harare
- Age
- 16 years to 24 years
- People
- 2,100 worldwide
- Run by
- RTI International
See details and how to joinNCT07666139 - No phaseNot yet taking people in ZimbabwePeer-led Service Delivery Model for Pregnant and Lactating Adolescent Girls and Young Women in Zimbabwe
- Where
- Empandeni Mission, Mawabeni, Shangani
- Age
- 15 years to 24 years
- People
- 600
- Run by
- University College, London
See details and how to joinNCT07546344 - Phase 2Not yet taking people in ZimbabwePhase 2b, Open Label, Multisite, Randomized Crossover Study of DPP Versus 2PR
- Where
- Harare
- Age
- 16 years to 39 years
- People
- 300 worldwide
- Run by
- HIV Prevention Trials Network
See details and how to joinNCT07288190 - No phaseNot yet taking people in ZimbabweMobile Health Supported Self-care Among Tertiary Education Students in Zimbabwe
- Where
- Harare
- Age
- 16 years to 60 years
- People
- 16,000
- Run by
- Liverpool School of Tropical Medicine
See details and how to joinNCT07403318 - Phase 1Taking peopleA Trial of a Gorilla Adenovirus Vectored Networked Epitopes Vaccine, Administered to Healthy Adults Living Without and With HIV.
- Where
- Harare
- Age
- 18 years to 50 years
- People
- 120 worldwide
- Run by
- International AIDS Vaccine Initiative
See details and how to joinNCT06617091 - No phaseTaking peopleHarnessing Male Peer Networks to Enhance Engagement With HIV Prevention
- Where
- Mutare
- Age
- 18 years and over
- People
- 3,591
- Run by
- University of Stellenbosch
See details and how to joinNCT06370923